Publications by authors named "Frederic Machet"

Claim this Profile
E
Eliapixant is a selective P2X3 receptor antagonist for the treatment of disorders associated with hypersensitive nerve fibers.
Adam J Davenport, Ioana Neagoe, Nico Bräuer, Markus Koch, Andrea Rotgeri, Frederic Machet

Sci Rep· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of (S,E)-3-(2-fluorophenyl)-N-(1-(3-(pyridin-3-yloxy)phenyl)ethyl)-acrylamide as a potent and efficacious KCNQ2 (Kv7.2) opener for the treatment of neuropathic pain.
Yong-Jin Wu, Charles M Conway, Li-Qiang Sun, Frederic Machet, Jie Chen

Bioorg Med Chem Lett· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble Abeta and cognitive function in aged F-344 rats and Tg2576 mice.
Mark D Lindner, John B Hogan, Rudolph G Krause, Frederic Machet, Clotilde Bourin

Behav Brain Res· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse effects of gabapentin and lack of anti-allodynic efficacy of amitriptyline in the streptozotocin model of painful diabetic neuropathy.
Mark D Lindner, Clotilde Bourin, Ping Chen, John F McElroy, John E Leet, Frederic Machet

Exp Clin Psychopharmacol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Sensitivity of abdominal radiography without preparation compared with computed tomography in the assessment of residual fragments after percutaneous nephrolithotomy].
Christophe Pires, Frédéric Machet, Laurent Dahmani, Jacques Irani, Bertrand Dore

Prog Urol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis